The European Breast Cancer Conference (EBCC9) held in Glasgow, Scotland from 19 to 21 March was the largest Breast Cancer Conference outside the USA and again provided a multidisciplinary setting for all professionals with a common interest in breast cancer to navigate, discuss, inform and educate themselves about this evolving disease landscape; to debate and deliberate about new data and developments; and to establish what it means for patient treatment and care. This report aims at giving a short overview of the most important data presented at the meeting. For a more complete overview we refer to the congress website

(BELG J MED ONCOL 2014;8(2):55–8)